Nurse Practitioner in Granite Falls, WA Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Linette N Mauya, Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 17501 Oak St, Granite Falls, WA 98252 Phone: 405-532-0876 |
Meggan Anderson, APRN-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 405 W Stanley St, Granite Falls, WA 98252 Phone: 360-691-2419 Fax: 360-691-0489 |
Crystal Ann Swain, ARNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 8709 163rd Ave Ne, Granite Falls, WA 98252 Phone: 206-778-3423 |
News Archive
Stryker announces results from clinical study of Trevo System on acute ischemic stroke
On February 2, at the Late-Breaking Science Session at the International Stroke Conference, Stryker announced the results of the TREVO Study (Thrombectomy REvascularization of large Vessel Occlusions in acute ischemic stroke). This was one of the first prospective, multi-center clinical studies of clot-removing stent retriever technology.
Surprising discovery about BH4 may rekindle interest in once-promising pathway
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, PhD, and chemist Kai Johnsson, PhD, his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief.
A precursor to remdesivir shows therapeutic potential for COVID-19
A new study points to the potential to use the remdesivir precursor, GS-441524, as a treatment choice for COVID-19.
Brain & Behavior Research Foundation announces recipients of NARSAD Young Investigator Grants
The Brain & Behavior Research Foundation today announced the award of its NARSAD Young Investigator Grants valued at more than $13 million to 191 of the world's most promising young scientists.
Change in gene may be underlying molecular defect in some colorectal cancers
Inactivation of a DNA repair gene may be an early step in the development of sporadic colorectal tumors, and detection of the molecular basis for this inactivation may ultimately be useful in risk assessment for colorectal cancer, according to a new study in the September 21 issue of the Journal of the National Cancer Institute.
› Verified 3 days ago